Establishment and neural differentiation of neural crest-derived stem cells (NCSCs) from human dental pulp in serum-free conditions by Solis-Castro, O.O. et al.
This is a repository copy of Establishment and neural differentiation of neural crest-derived
stem cells (NCSCs) from human dental pulp in serum-free conditions.




Solis-Castro, O.O. orcid.org/0000-0001-7596-3811, Boissonade, F.M. and Rivolta, M.N. 
(2020) Establishment and neural differentiation of neural crest-derived stem cells (NCSCs)






This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
T I S S U E - S P E C I F I C P ROG E N I T O R AND S T EM C E L L S
Establishment and neural differentiation of neural
crest-derived stem cells (NCSCs) from human dental pulp in
serum-free conditions
Oscar O. Solis-Castro1,2,3 | Fiona M. Boissonade2,3 | Marcelo N. Rivolta1,3
1Centre for Stem Cell Biology, Department of
Biomedical Science, University of Sheffield,
Sheffield, UK
2School of Clinical Dentistry, University of
Sheffield, Sheffield, UK
3The Neuroscience Institute, University of
Sheffield, Sheffield, UK
Correspondence
Fiona M. Boissonade, PhD, Faculty of
Medicine, Dentistry and Health, School of
Clinical Dentistry, University of Sheffield,
19 Claremont Crescent, Sheffield, S10 2TA,
UK.
Email: f.boissonade@sheffield.ac.uk
Marcelo N. Rivolta, PhD, Centre for Stem Cell
Biology, Department of Biomedical Science,
University of Sheffield, Alfred Denny Building,
Western Bank, Sheffield S10 2TN, UK.
Email: m.n.rivolta@sheffield.ac.uk
Abstract
The potential of obtaining cell cultures with neural crest resemblance (neural crest-
derived stem cells [NCSCs]) from dental-related tissues, including human dental
pulp cells (hDPCs), has been discussed in the literature. However, most reports
include the use of serum-rich conditions and do not describe the potential for neu-
ral differentiation, slowing translation to the clinic. Therefore, we aimed to culture
and characterize NCSCs from the human dental pulp in vitro and evaluate their abil-
ity to differentiate into neurons; we also investigated the effectiveness of the addi-
tion of BMP4 to enhance this potential. Cultures were established from a varied
cohort of patient samples and grown, as monolayers, in serum, serum-free, and also
under sphere-aggregation conditions to induce and identify a NCSC phenotype.
hDPC cultures were characterized by immunocytochemistry and reverse transcrip-
tion quantitative polymerase chain reaction. Monolayer cultures expressed stem
cell, neural progenitor and neural crest-related markers. Culturing hDPCs as neuro-
spheres (hDPC-NCSCs) resulted in an increased expression of neural crest-related
genes, while the addition of BMP4 appeared to produce better NCSC characteris-
tics and neural differentiation. The neural-like phenotype was evidenced by the
expression of TUJ1, peripherin, NFH, TAU, SYN1, and GAP43. Our results describe
the establishment of hDPC cultures from a large variety of patients in serum-free
medium, as NCSC that differentiate into neural-like cells, as well as an important
effect of BMP4 in enhancing the neural crest phenotype and differentiation of
hDPCs.
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1 | INTRODUCTION
Oral-derived stem cells (OSCs) have been generally characterized
in vitro as mesenchymal stem cells (MSCs). These OSCs include the
widely studied dental pulp cells as well as stem cell populations
derived from other novel oral sources such as periapical Cyst-MSCs
(PCy-MSCs). OSCs are regarded as good candidates for autologous
cell therapies in regenerative medicine due to their multipotent differ-
entiation, proliferative capacity, and accessibility (as reviewed by
Tatullo et al).1
However, a factor that can delay translation of OSCs into the
clinic is that the isolation, culture, and characterization of these stem
cell populations have been commonly performed in medium con-
taining fetal bovine serum (FBS; recently reviewed by Luo et al2 and
Rodas-Junco et al3), which is inappropriate for most applications in
man. Hence, there is a need for protocols to establish cell cultures in
conditions that would be more appropriate for advancing their trans-
lational use.4,5 Thus, it is important to develop methods that would
allow the establishment of cultures in serum-free and/or xeno-free
conditions that could comply with clinical-grade manufacturing stan-
dards in the near future. At the same time, there is a need to describe
in more detail the possibility of using these cells from samples
obtained from a wide variety of patients that could realistically resem-
ble common clinical scenarios.
Most dental-related stem cell sources are believed to derive from
the neural crest,6 and because of this there is an increasing interest in
the study of their neural crest-derived stem cell (NCSC) characteris-
tics.7-9 In contrast to MSCs from non-neural crest origin, these NCSCs
could prove particularly useful to restore neural cell types due to their
molecular resemblance to embryonic neural crest cells.10,11
In this regard, there is little information about the identification
and isolation of a human NCSC population specifically from human
dental pulp cells (hDPCs) of adult, permanent teeth, and only a small
number of key direct applications have been reported.12-14 Thus, it is
highly relevant to further our understanding of NCSCs from hDPCs,
and also to test their proposed potential in relevant models of nerve
regeneration.
Therefore, we present here a detailed description of the estab-
lishment and characterization of hDPCs grown in serum-free media
in vitro, the characterization of their molecular NCSC signature, and
the role of BMP4 in enhancing this signature. In addition, we present
proof of concept that these NCSCs, generated under serum-free con-
ditions from hDPCs, can derive neural-like cells, proposing them as
candidates for neural regeneration treatments.
2 | MATERIALS AND METHODS
2.1 | Dental pulp collection
The study was conducted in accordance with ethical approval granted
by the Leeds East Research Ethics Committee of the UK National
Research Ethics Service (reference: 15/YH/0308; protocol: STH19019).
Human dental pulp was isolated from samples collected with written
informed consent from patients at the Charles Clifford Dental Hospital,
Sheffield, UK. Details of the patients' age and the condition and position
of the tooth are provided in Table 1. Immediately after extraction,
the samples were transported in ice-cold PBS with 1× Penicillin-
Streptomycin (1× P/S; 100 IU/mL-100 μg/mL; GIBCO, Paisley, UK) to
the laboratory for processing.
2.2 | Dental pulp cell culture establishment
Dental pulp was extracted by making a longitudinal groove on the
tooth with an electric drill cooled under running water and sectioning
the tooth with a mallet and osteotome to expose the pulp. The dental
pulp was removed, cut into small pieces and digested with collagenase
IV (3 mg/mL; GIBCO) for 60 minutes, aided by pipetting every
30 minutes. The dissociated tissue was passed through a 100 μm
strainer, washed with PBS, and centrifuged for 5 minutes at 400g. The
pellet was resuspended directly into either: (a) standard medium:
DMEM, 1× P/S, 1× Glutamax (GIBCO), 10-4 Ascorbic Acid (Sigma,
Dorset, UK), 20% FBS (GIBCO); (b) otic stem cell full medium
(OSCFM): DFNB (DMEM:F12 (GIBCO), 1% N2 (GIBCO), 2% B27
(GIBCO), 1× P/S (SIGMA), 20 ng/mL bFGF (R&D Systems, Abingdon,
UK), 50 ng/mL IGF (R&D Systems), 20 ng/mL EGF (R&D Systems); or
(c) bone morphogenic protein 4 (BMP4) medium: OSCFM sup-
plemented with 10 ng/mL BMP4 (R&D Systems). OSCFM and BMP4
cultured cells were grown on laminin-coated six well plates
(2.5 μg/cm2; Cultrex, Gaithersburg, MD). The time between sample
collection and their final deposition in culture conditions was less than
4 hours. The cultures remained undisturbed for the first 4 days. From
day 4, half a volume of the respective media was replaced. From day
12 onward, all medium was replaced every 2 to 3 days.
Significance statement
This work details the acquisition of cells from human dental
pulp and describes their establishment and growth in
preclinically relevant, serum-free culture conditions, in com-
parison to standard serum-rich cultures. In contrast with the
current literature, this article described in greater detail the
nature and condition of the samples used from a large group
of patients, allowing for a greater understanding in relation
to clinical translation. Results provide evidence of neural
crest-related markers in all our growing conditions, and the
improvement of a neural crest-like phenotype by growing
human dental pulp cells (hDPCs) in 3D neurospheres. Impor-
tantly, this article provided evidence that hDPCs that are
characterized as neural crest-derived stem cells can differ-
entiate into neural-like cells, as well as describing an impor-
tant novel effect of BMP4 on hDPC neural crest-like
phenotype.
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TABLE 1 Human dental pulp samples
Sample ID Patient age Sex Remarks (tooth position) Medium Successful
1 61 F Periodontal disease FBS No
2 52 F Caries (5) FBS No
3 19 F Non-carious, unerupted (8) FBS Yes
4 23 F Non-carious (8) FBS Yes
5 22 F Non-carious (8) FBS Yes
6 20 F Fragmented (8) FBS Yes
7 27 F Minimal Caries (8) FBS Yes
9 28 F Fragmented (8) N/A N/A
16 16 F Non-carious (8) FBS Yes
16 16 F Non-carious (8) OSCFM Yes
17 22 M Fragmented (8) FBS Yes
18 30 F Non-carious (8) FBS Yes
19 27 F Non-carious (8) (facial pain) FBS Yes
19 27 F Non-carious (8) (facial pain) OSCFM Yes
20 27 F Non-carious (8) (facial pain) FBS Yes
20 27 F Non-carious (8) (facial pain) OSCFM Yes
21 21 M Non-carious (8) OSCFM Yes
22 24 F Non-carious (8) FBS Yes
23 24 F Minimal caries (8) FBS Yes
24 26 F Non-carious (8) OSCFM Yes
25 33 F Non-carious (8) BMP4 Yes
26 15 F Minimal caries (7) OSCFM No
27 20 F N/S (8) OSCFM No
28 36 F Minimal caries (8) N/S No
29 36 F Non-carious (8) BMP4 Yes
32 35 M Fragmented (?) OSCFM No
34 24 F Non-carious (8) BMP4 No
34 24 F Non-carious (8) OSCFM Yes
37 38 F N/S-Mobile (8) BMP4 No
38 38 F Periodontal disease (?) OSCFM No
39 17 M Non-carious (3) BMP4 No
39 17 M Non-carious (3) OSCFM Yes
40 17 M Non-carious (3) BMP4 Yes
41 17 M Non-carious (3) BMP4 Yes
42 20 F Non-carious (8) BMP4 No
43 22 F Non-carious (8) BMP4 Yes
44 29 M Non-carious (8) FBS Yes
45 29 M N/S (8) OSCFM Yes
46 N/S N/S N/S OSCFM Yes
47 27 M Minimal caries (8) BMP4 No
48 27 M Minimal caries (6) FBS Yes
49 39 M Fragmented (8) OSCFM No
50 28 M Minimal caries (6) BMP4 No
51 31 M Fragmented (8) FBS No
52 45 M Fragmented (8) BMP4 No
53 21 F Non-carious (8) BMP4 No
(Continues)
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Primary cultures were passaged at week 4, and cultures able to
proliferate and survive at least four passages were described as suc-
cessful cultures (“Yes” or “No”; Table 1). Following the initial passage,
cultures were passaged every week at 5000 to 10 000 cells/cm2 using
1:10 Trypsin EDTA (TE; Sigma) for FBS cultures and 1:80 TE for
OSCFM and BMP4 cultures.
2.3 | Calculation of cumulative cell
doublings (CCDs)
The number of living cells was obtained by trypan blue staining, and
cell number was counted using the automated cell counter TC20 (Bio-
rad, Hertfordshire, UK; particle size range 9-21 μm). CCD of living
cells was calculated using the following formula:
CCD=3:32 logUCY − log Ið Þ + X
where UCY is the final cell count, I is the initial cell number seeded,
and X the previous cell doubling number (American Type Culture
Collection).
2.4 | Neurosphere formation
hDPC cultures were detached with the corresponding Trypsin EDTA
treatment (as described above) and resuspended in sphere medium:
DFNB, 1× P/S (Sigma), 20 ng/mL bFGF (R&D Systems), 20 ng/mL EGF
(R&D Systems) at 10 000 cells per 100 μL in ultra-low attachment cul-
ture plates (Costar, UK). Neurospheres were fed by adding 50 μL of the
medium at day 3 and 6. The number of individual spheres and their
diameter was measured on day 4. Neurospheres were harvested or used
in downstream applications from day 6 to 8. Where indicated, 10 ng/mL
BMP4 (R&D Systems) was supplemented to the sphere medium.
2.5 | Neural differentiation of hDPC-NCSCs
Neurospheres were induced as described by Gervois et al15 with mod-
ifications. At day 6 to 8, neurospheres were transferred to Poly-
ornithine (0.01%; Sigma)/Laminin (2.5 μg/cm2; Cultrex) coated plates
in neuralizing medium consisting of DFNB, 30 ng/mL NT3 (Prepotech,
London, UK) and 1 mM dbcAMP (Tocris, Abingdon, UK). The medium
was replaced every 2 to 3 days for up to 2 weeks.
2.6 | Transference of hDPC-FBS cells to OSCFM
and BMP4 conditions
hDPC-FBS cells were transferred to the conditions described for
OSCFM and BMP4 cultures for 7 days. Cells maintained in FBS condi-
tions were used as a control. After the 7 days of the transference,
hDPC-NCSC neurospheres were formed. hDPC-neurospheres were
then induced for neural differentiation as described above.
2.7 | Neurosphere sectioning
After fixation (see below), hDPC neurospheres were subjected to a
sucrose gradient of 7.5%, 15%, 22%, and 30% sucrose (12-24 hours
each; 4C), and transferred to optimal cutting temperature (OCT) solu-
tion for 24 hours (4C). The tissue was then fast-frozen on a dry
ice/methyl-butane bath. Cryosectioning was then performed in a
Bright OTF5000 cryostat in sections of 5 to 10 μm.
TABLE 1 (Continued)
Sample ID Patient age Sex Remarks (tooth position) Medium Successful
53 21 F Non-carious (8) OSCFM Yes
54 17 F Non-carious (2) FBS No
54 17 F Non-carious (2) OSCFM No
55 17 F Non-carious (5) BMP4 No
56 37 F N/S BMP4 No
56 37 F N/S OSCFM No
57 37 F Minimal caries (?) FBS Yes
57 37 F Minimal caries (?) OSCFM Yes
58 37 F Minimal caries (?) BMP4 No
58 37 F Minimal caries (?) FBS Yes
59 N/S N/S Non-carious (?) FBS Yes
60 47 M Minimal caries (8) BMP4 No
Note: In some cases, the same sample digest was split and cultured in two different media (samples 19, 20, 54, 56, 57, 58). Numbers in parentheses indicate
tooth position.
Abbreviations: BMP4, bone morphogenic protein; F, female; FBS, fetal bovine serum; hDPC, human dental pulp cells; M, male; N/A, not applicable; N/S,
not specified; (?), not specified; OSCFM, otic stem cell full medium.
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2.8 | Fixing, immunocytochemistry, and imaging
Cells and spheres were fixed with 4% Methanol-free PFA (Alfa Aestar,
Lancashire, UK) at room temperature for 10 minutes. For immunocy-
tochemistry, cultures were blocked for 1 hour with 5% normal donkey
serum-PBST (Sigma; Blocking solution). Primary antibodies were
added and left overnight at 4C. Secondary antibodies were added in
blocking solution (as above) for 1 hour at room temperature together
with DAPI nuclei counterstaining (1:100).
Antibodies and dilutions: RBT NFH (NF200; 1:100; Sigma, N4142),
RBT PER (1:100; Millipore, Watford, UK, AB1530), MSE TUJ1 (1:100;
Biolegend, London, UK, 801202), RBT TAU (1:100; Santa Cruz Biotech-
nology, Heidelberg, Germany, [H-150] 5587), RBT SOX2 (1:100;
Millipore, AB5603), MSE AP2a (1:100; Santa Cruz Biotechnology,
SC12726), MSE NESTIN (1:100; [10c2], Santa Cruz Biotechnology,
SC23927), MSE P75 supernatant (1:10; Centre for Stem Cell Biology,
Sheffield, UK ME 20.4), MSE SLUG (1:100; Santa Cruz Biotechnology,
[A-7] SC166476), MSE SNAIL1 (1:100; Santa Cruz Biotechnology,
[G-7] SC271977), Goat SOX10 (1:75; Santa Cruz Biotechnology,
SC17342), RBT SOX9 (1:100; Millipore, AB5535), MSE STRO-1 (1:100;
R&D Systems, MAB1038). DNKa-MSE Alexa 488 (1:250; Invitrogen,
Loughborough, UK, A21202), DNKa-RBT-Alexa 568 (1:250; Invitrogen,
A10042), DNKa-GOAT Alexa 568 (1:250; Invitrogen, A11057).
The EVOS cell imaging system and InCell Analyzer inverted
microscopes were used for fluorescent and brightfield imaging. FIJI
image software was used for image processing and analysis. Negative
controls were calculated by omitting the primary antibody during the
immunocytochemistry.
2.9 | P75 and STRO-1 positive cell population
counting
Cultures positively stained for nerve growth factor receptor (P75) and
STRO-1 at passage 0 and between passage 2 and 4 were manually
counted and the percentage of positive cells was calculated based on
the total cell number defined by DAPI nuclei staining.
2.10 | RNA extraction and cDNA synthesis
The Qiagen microkit (Qiagen, Manchester, UK) was used to extract
RNA from the cell cultures according to the manufacturer's instruc-
tions and quantified using a Nanodrop spectrophotometer. For cDNA
synthesis, at least 200 ng of RNA was used with the Superscript IV
retro transcriptase (Thermofisher, Loughborough, UK) according to
the manufacturer's instructions.
2.11 | Direct RT-qPCR preparation
hDPC-FBS transferred into the other culture conditions (FBS,
OSCFM, and BMP4) and induced to neural differentiation (refer to
Figure 6D) were analyzed using a Cells to CT kit (Thermofisher)
according to the manufacturer's instructions.
2.12 | Quantitative polymerase chain reaction
(RT-qPCR)
Reverse transcription quantitative polymerase chain reaction was per-
formed with Taqman probes using the Thermofisher QuantStudio 12 k
Flex Real-time PCR system. The reactions were prepared with at least
1 ng/μL of cDNA. The master-mix, assays, and water volumes were
used according to the concentrations specified by the manufacturer's
instructions in a final volume of 7.5 μL per reaction in quadruplicate.
The relative expression analysis was performed using the 2ddCT
method.
Taqman probes: RPLP0 (Hs00420895_gH), SOX2 (Hs00602736_s1),
OCT4/POUF5F1 (Hs04260367_gH), NANOG (Hs02387400_g1), SOX10
(Hs00366918_m1), P75/NGFR (Hs00609976_m1), NESTIN (Hs04187831_
g1), SNAIL1 (Hs00195591_m1), AP2a/TFAP2A (Hs01029413_m1),
SYN1 (Hs00199577_m1), NFH/NEFH (Hs00606024_m1), GAP43
(Hs00967138_m1).
2.13 | Statistical analysis
One-way ANOVA followed by a Sidak's or Tukey test for pairwise
comparison was made to determine differences. A linear regression
analysis was used to determine slope differences. The tests were run
in GraphPad Prism version 8.3.0 (GraphPad Software, San Diego,
California).
3 | RESULTS
3.1 | hDPCs can be established in serum-free
conditions from a variety of samples
With the purpose of establishing in vitro hDPC cultures, 48 teeth
(molars, premolars, canines, and incisors) were collected with written
informed consent from patients at the Charles Clifford Dental Hospi-
tal, Sheffield, UK. Patient data collected comprised age, sex, and rea-
son for tooth extraction as described by the clinical staff (Table 1).
The age of the patients ranged from 15 to 61 years, with a mean of
27 (±8.9) years, a median of 26 years and a mode of 27 years. Carious
teeth were included only if the caries was considered by the clinical
staff to be minimal. Samples that were fragmented during tooth
removal were omitted, as were the samples from the two oldest
patients with poor, overall oral health (severe periodontal disease,
pulpitis; samples 1 and 2; Table 1).
To determine whether hDPC primary cultures could be
established in serum-free, neurogenic conditions from the beginning,
freshly dissociated hDPCs were seeded in either OSCFM (a medium
used previously to isolate otic progenitors from the fetal human
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cochlea16) or OSCFM supplemented with BMP4, and compared with
seeding in standard 20% serum-DMEM. The in vitro efficiency of each
culture system was determined by recording the number of cultures
that managed to proliferate and be passaged more than four times.
The graphs shown in Figure 1A-F represent the percentage of
successful cultures. The highest success rate of surviving cultures was
FBS (93%, n = 15/16), followed by OSCFM (81%, n = 9/11) and
BMP4 (35%, n = 5/14; Figure 1A). To consider common situations in
the clinical setting, we also included mildly carious teeth in our experi-
ments. Overall, dental pulp culture establishment from non-carious
F IGURE 1 hDPC culture establishment. The percentage success for individual samples to grow in vitro and be cultured for at least four
passages was calculated under the following criteria: A, total samples collected for culture establishment; B, tooth condition; C, overall success
associated with age; D, success associated with age in cultures grown in FBS medium; E, success associated with age in cultures grown in OSCFM
medium; and F, success associated with age in cultures grown in BMP4 medium. Comparison of independent cultures grown in different
conditions and changes in relation to their passage number: G, FBS cultures; H, OSCFM cultures; I, BMP4 cultures. J, hDPC-OSCFM (upper) and
hDPC-BMP4 (lower) at passage 0 showing neural-like cells not present in later passages (arrows). K, Cumulative cell doublings describing the
proliferative ability of hDPC cultures able to be passaged for more than four passages in the different culture conditions. Overall slopes and
elevation were statistically similar (P > .05). Scale bars: G-I = 400 μm; J = 200 μm. BMP4, bone morphogenic protein 4; FBS, fetal bovine serum;
hDPC, human dental pulp cells; hDPC-FBS, hDPC grown in 20% FBS, hDPC-OSCFM, hDPC grown in OSCFM; hDPC-BMP4, hPDC grown in
OSCFM supplemented with BMP4; OSCFM, otic stem cell full medium
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teeth had 76% efficiency (n = 23/30), while in carious teeth the effi-
ciency dropped to 54% (n = 6/11; Figure 1B).
We also calculated the overall culture efficiency in relation to age,
by grouping the samples in the following age groups: group 1:
15-20 years (50%, n = 6/12), group 2: 21-30 years (80%, n = 17/21),
and group 3: >30 years (66%, n = 6/9; Figure 1C). However, consider-
ation should also be made for each culture condition. FBS cultures
were highly successful throughout, with 100% in group 2 (n = 10/10)
and group 3 samples (n = 2/2), and the lowest in the youngest samples
(n = 2/3), with 66% success (Figure 1D). OSCFM cultures were
established with greater frequency from samples in the middle group
(100%; n = 7/7), followed by the youngest with 40% (n = 2/5) and
oldest with 50% (n = 1/2) success rate (Figure 1E). On the other hand,
BMP4 cultures had the lowest efficiency rate overall with the
F IGURE 2 Human dental pulp cells (hDPCs) characterization. A, Basal relative expression of pluripotent and neural crest markers in hDPC
cultures established directly into FBS, OSCFM, or BMP4 medium at passages 0 to 7. Each data point represents independent cultures normalized
to the expression of the embryonic stem cell line H14 S9 established as 1 (not illustrated). B, Representative images of the immunocytochemistry
of neural crest-related markers and STRO-1 expressed in at least three independent cultures of hDPCs at passages 0 to 7. P75 panels represent
cultures at passage 0. Scale bar = 200 μm. C) Quantification of STRO-1+ve cells at different passage number in the three different conditions in
independent experiments. D, Quantification of P75+ve cells at different passage number in the three different conditions in independent
experiments. **P < .01; one-way ANOVA followed by Sidak's pairwise comparison test. n is the number of independent cultures. ANOVA,
analysis of variance; BMP4, bone morphogenic protein 4; FBS, fetal bovine serum; OSCFM, otic stem cell full medium
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youngest group having 40% success rate (n = 2/5), the middle group
20% (n = 1/5), and the oldest aged patient group 50% (n = 2/4;
Figure 1F).
Culture passaging showed an effect on cell morphology and den-
sity regardless of the initial culture condition. Distinct differences in
cell morphology were evident between our culture conditions: hDPC-
FBS (Figure 1G), hDPC-OSCFM (Figure 1H), and hDPC-BMP4
(Figure 1I). Notably, neural-shaped cells were evident at passage 0 in
the neurogenic conditions OSCFM and BMP4 but disappeared soon
after passaging (Figure 1J, arrows). Once established, we calculated
CCDs. After comparison of the growth curves, the analysis showed no
differences between the growth of hDPC in the different culture con-
ditions (Figure 1K).
3.2 | hDPC cultures express neural crest-related
markers
We aimed to define the core molecular signature of hDPCs when cells
were grown in two-dimensional, monolayer cultures in the three dif-
ferent conditions. A relative expression analysis by RT-qPCR was per-
formed to identify the expression of pluripotent stem cell and neural
crest-related genes. When compared to a human pluripotent embry-
onic cell line, low relative expression levels of OCT4, NANOG, and P75
were detected in all our culture conditions. NESTIN was expressed in
all culture conditions with a higher relative expression. Notably, SOX2
and SOX10 expression were undetected. None of the evaluated
markers presented a statistically significant difference among FBS,
OSCFM, or BMP4 conditions (Figure 2A).
Using immunocytochemistry for common neural crest markers,
the presence of SLUG, SNAIL1, NESTIN, SOX9, and P75 revealed a
characteristic NCSC signature in monolayer cultures (Figure 2B). How-
ever, markers such as SOX10 (not shown) and P75 were not recog-
nized or only detected at an earlier passage number, respectively. In
particular, P75 and STRO-1 were present in some cells within the
cultures, evidencing culture heterogeneity (Figure 2B). We further
quantified culture heterogeneity by calculating the percentage of
STRO-1+ve and P75+ve cells at passage 0 and comparing them to a
later passage. The STRO-1+ve population increased significantly after
culture passaging in all media conditions, while P75 was only detect-
able at passage 0, suggesting subpopulations change dynamically
during passages in culture (Figure 2C,D).
3.3 | NCSC markers are enhanced when hDPCs
are grown as spheres
Due to the evident changes in sub-populations occurring during
expansion as monolayers (Figure 2C,D), it was hypothesized that cul-
turing hDPCs as 3D aggregates could drive them into a more stable,
F IGURE 3 NCSC neurospheres
formation. A, The workflow of
neurosphere formation from all culture
conditions. B, hDPCs from FBS, OSCFM,
and BMP4 conditions cultured in low-
attachment wells. C, Sphere number and
diameter per well were calculated from at
least 10 wells per independent culture
(n = 3 or 6). Neurospheres were counted
if diameter >100 μm. *P < .05, **P < .01;
one-way ANOVA followed by Tukey's
test for pairwise comparison. n is the
number of independent cultures. ANOVA,
analysis of variance; BMP4, bone
morphogenic protein 4; FBS, fetal bovine
serum; hDPC, human dental pulp cells;
NCSC, neural crest-derived stem cells;
OSCFM, otic stem cell full medium
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NCSC phenotype (hDPC-NCSC). Cells initially expanded as a mono-
layer were passaged and forced to aggregate into neurospheres for
characterization.
An equal number of cells from each initial culture condition were
transferred to low attachment culture plates, and sphere formation
(as number of spheres per well and diameter) was assessed after
4 days in culture (Figure 3A,B). Overall, no significant difference was
observed in sphere number among our culture conditions, and a
statistically significant smaller diameter was observed in spheres
derived from BMP4 cultures (Figure 3C).
Neurospheres were then analyzed by immunocytochemistry to
identify neural crest-related markers. hDPC-FBS- (Figure 4A), hDPC-
OSCFM- (Figure 4B), and hDC-BMP4- (Figure 4C) neurospheres
labeled positively for SOX2, SOX9, NESTIN, SLUG, and SNAIL1. How-
ever, the markers AP2a, SOX10, and P75 were predominantly present
in hDPC-BMP4 neurospheres (Figure 4C), while were almost
F IGURE 4 NCSC neurospheres
characterization. Immunolabeling for
neural crest-related markers in
hDPC-neurospheres derived from A,
hDPC-FBS cultures; B, hDPC-
OSCFM cultures; and C, hDPC-
BMP4 cultures. “No 1ry CTL”:
controls with no primary antibody,
showing a representative view of
neurospheres labeled with the
secondary antibodies only. D,
Neurospheres from all conditions
(FBS-grey, OSCFM-blue and
BMP4-orange) were analyzed by
RT-qPCR for the expression of
NCSC markers: SNAIL1, P75,
SOX10, and AP2a. Each bar
represents an independent
neurosphere culture that was
normalized and compared to their
own monolayer counterpart (dotted
line = 1). Error bars represent
technical replicates of each
independent sample. Scale
bars = 100 μm (A-C). A-C,
Representative pictures of multiple
spheres from at least three
independent cultures. A one-way
ANOVA followed by a Sidak's
multiple comparison test was made
to determine differences. *P < .05,
**P < .01, ***P < .001, ****P < .0001.
1ry, primary; BMP4, bone
morphogenic protein 4; CTL, control;
FBS, fetal bovine serum; hDPC,
human dental pulp cells; hDPC-FBS,
hDPC grown in 20% FBS, hDPC-
OSCFM, hDPC grown in OSCFM;
hDPC-BMP4, hPDC grown in
OSCFM supplemented with BMP4;
NCSC, neural crest-derived stem
cells; OSCFM, otic stem cell full
medium
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undetected in the hDPC-FBS and hDPC-OSCFM neurospheres
(Figure 4A,B). Interestingly, SOX2 was expressed by neurospheres
from all culture conditions, while appeared undetected by RT-qPCR in
the earlier monolayer cultures.
To support the observation made by immunocytochemistry, we
also studied the expression of SNAIL1, P75, SOX10, and AP2a quanti-
tatively by RT-qPCR. To do this, we analyzed the relative expression
levels of each neurosphere sample in comparison to their own mono-
layer counterpart. Overall, P75 and SNAIL1 expression was signifi-
cantly higher in the majority of independent neurospheres from all
conditions (Figure 4D), whereas SOX10 and AP2a were upregulated
only in a few samples grown as neurospheres (Figure 4D). Overall,
immunocytochemistry and RT-qPCR data suggested that hDPC-
derived spheres presented a more robust upregulation of neural crest-
related markers in relation to their monolayer counterparts, thus
supporting a NCSCs phenotype (hDPC-NCSCs). The sample-to-
sample variation that can be observed from the RT-qPCR data
evidenced the natural variability and heterogeneity of independent
donors and passage number.
3.4 | BMP4 can enhance the NCSC phenotype
from hDPC-FBS cultures
As BMP4 has been shown to drive NCSC identity,17 we evaluated
whether BMP4 could affect the NCSC phenotype if used during
F IGURE 5 NCSC
neurospheres characterization
and BMP4 effect in NCSC
phenotype. A, The workflow of
neurosphere formation from
independent hDPC-FBS and
hDPC-OSCFM cultures with and




supplemented with 10 ng/mL
BMP4 during sphere formation
phase. The expression of neural-
crest related markers: Ap2a,
SNAIL1, and P75 in the
neurospheres was analyzed by
RT-qPCR and compared to the
monolayer parental line. Error
bars represent technical
replicates of each independent
sample. A one-way ANOVA
followed by a Tukey's test for
pairwise comparison was made to
determine differences. *P < .05,
**P < .01, ***P < .001,
****P < .0001. BMP4, bone
morphogenic protein 4; FBS, fetal
bovine serum; hDPC, human
dental pulp cells; hDPC-FBS,
hDPC grown in 20% FBS, hDPC-
OSCFM, hDPC grown in OSCFM;
hDPC-BMP4, hPDC grown in
OSCFM supplemented with
BMP4; NCSC, neural crest-
derived stem cells; OSCFM, otic
stem cell full medium
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F IGURE 6 hDPC-NCSCs neural differentiation. Neural differentiation of NCSCs. Representative pictures from at least three independent
cultures from A, hDPC-FBS; B, hDPC-OSCFM; and C, hDPC-BMP4 cultures. The expression of neural-related markers TUJ1, NFH, peripherin
(PER), and TAU was analyzed by immunocytochemistry in NCSC induced to neural differentiation (NEU) and compared to their undifferentiated
control (CTL). Neural morphology and an apparently stronger signal were observed in hDPC-NEU cells compared to controls (A-C). Only
BMP4-NEU showed expression of the four analyzed markers (C). Scale bar = 100 μm (A-C). D, hDPC-FBS cells were transferred to OSCFM and
BMP4 culture conditions before neurosphere formation and were subject to neural differentiation. The gene expression of neural related markers
GAP43, NFH, and SYN1 were upregulated mainly in the neural differentiated cells from hDPC-FBS transferred to the BMP4 condition (FBS-
BMP4-NEU). One-way ANOVA followed by Tukey's test for pairwise comparison. *P < .05, ****P < .0001. BMP4, bone morphogenic protein 4;
CTL, control; FBS, fetal bovine serum; hDPC, human dental pulp cells; hDPC-FBS, hDPC grown in 20% FBS, hDPC-OSCFM, hDPC grown in
OSCFM; hDPC-BMP4, hPDC grown in OSCFM supplemented with BMP4; NCSC, neural crest-derived stem cells; OSCFM, otic stem cell full
medium
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sphere formation rather than during culture establishment (Figure 5A).
Two hDPC-FBS cultures and one hDPC-OSCFM culture (also included
in the previous analysis; Figure 5B) were supplemented with BMP4
during sphere aggregation. RT-qPCR was used to determine any partic-
ular change in the NCSC phenotype and compared to the neurosphere
conditions described above, as well as the cells grown as monolayers
(baseline control, CTL). As seen before, AP2a showed the most limited
upregulation in which only the 53OSCFM neurospheres showed a posi-
tive regulation when supplemented with BMP4 (Figure 5B). HNK-1
presented a significant upregulation in two of the three independent
samples analyzed. Interestingly, the three hDPC cultures selected for
this experiment showed a significant upregulation of SNAIL1 and P75
expression in comparison to both CTL and neurospheres without
BMP4 (except P75- 48FBS Sphere vs 48FBS sphere+BMP4, where the
difference showed a trend but was not large enough to be significant).
All the evidence together suggests that the addition of BMP4 to the
neurospheres can induce even higher relative expression levels of
important neural crest-related genes.
3.5 | hDPCs-NCSCs differentiate in vitro into
neural-like cells
hDPC-NCSCs (neurospheres) derived from every initial experimental
condition (Figure 3A) were induced to differentiate into neurons by cul-
turing them for up to 2 weeks with dbcAMP and NT3. As control,
equivalent hDPC-NCSCs were transferred to the neural differentiation
media, without dbcAMP and NT3. Compared to the undifferentiated
controls, many hDPCs-NCSCs-derived cells presented a neuronal-like
morphology extending projections and a qualitatively higher intensity
of the neuronal markers TUJ1 and peripherin (PER; Figure 6A-C). NFH
was also expressed in the neural differentiated group colocalizing with
TUJ1 in cultures from hDPC-OSCFM and hDPC-BMP4 (Figure 6B,C),
but not from hDPC-FBS cultures (Figure 6A). Furthermore, TAU
expression was only detected in neuronal differentiated cells from
hDPC-BMP4 cultures (Figure 6C). Notably, cells with non-neuronal
morphology were frequently visible in neural induced cultures; addi-
tionally, cells were in some cases unable to grow out from the neuro-
spheres or were nonviable (not shown).
3.6 | Neural differentiation from hDPC-FBS
cultures can be enhanced when transferred to OSCFM
and BMP4 culture conditions
To further explore the ability of BMP4 to support neurogenic cultures,
hDPC-FBS cells were transferred to OSCFM and BMP4 conditions for
7 days and then induced to neurosphere formation and neural differ-
entiation (Figure 6D). RT-qPCR was used to analyze the neural-related
genes GAP43, NFH, and SYN1 after neural differentiation (Figure 6D).
As a control, we used the parental hDPC-FBS monolayer culture
(Figure 6D). hDPC-FBS cells transferred to OSCFM before neu-
ralization (FBS-OSCFM-NEU) presented a similar behavior in
comparison to neuralized cells from the initial FBS conditions (FBS-
NEU), as judged by the expression levels of GAP43 and SYN1. Inter-
estingly, GAP43 and NFH were significantly overexpressed in the
hDPC-FBS cells transferred to the BMP4 conditions before neural dif-
ferentiation (FBS-BMP4-NEU), in comparison to the rest of the exper-
imental groups. Furthermore, FBS-BMP4-NEU cells also presented a
higher significant upregulation of SYN1 when compared to the control
group (Figure 6D).
4 | DISCUSSION
In the present work, we have described the establishment of dental
pulp cultures from a wide variety of tooth sample conditions and ages.
The range of samples presented allowed us to extract critical data in
terms of efficiency, patient age, and sample condition, which should
be considered for the translational research of hDPCs, and which are
not commonly reported from such a varied sample cohort as this one.
One of the most complete reports previously available, described a
set of 40 samples from patients aged 18 to 30 years, showing 78%
success rate to grow in vitro (but under standard FBS conditions),18
which is similar to the overall efficiency found in the present work.
We have accounted for the presence of caries in our samples, and
have shown that it is possible to extract viable cells of similar identity
from affected teeth, although at a reduced efficiency (Table 1).
We have shown that hDPC can be established in OSCFM directly
from the primary tissue with an efficiency of 81%, providing evidence
of the suitability of this medium to be used for the establishment and
expansion of hDPCs in culture. On the other hand, successfully
established hDPC-BMP4 cultures behaved similarly to hDPCs in FBS
and OSCFM media, as judged by marker expression and CCDs. Never-
theless, the efficiency of establishing cultures in BMP4 was lower,
with only a third of the attempts being successful. The need to use
serum-free and xeno-free conditions for dental pulp cell cultures has
been recognized, and several authors have described the growth of
hDPC in defined media.4,5,14,19-21 However, most of the
abovementioned reports included serum in their initial culture estab-
lishment, jeopardizing the use of those cultures for translational appli-
cations including autologous cell therapies.4,5,14,19-22
We characterized hDPCs grown under OSCFM and BMP4 condi-
tions by RT-qPCR, and compared them to those derived in the pres-
ence of serum. We explored whether markers of pluripotency such as
SOX2, NANOG, and OCT4 were expressed by our cultures, since these
have been identified before in hDPCs and other oral-derived NCSCs,
fueling the claim that these populations could be pluripotent.23-26
Nevertheless, most of these reports have not used sensitive, quantita-
tive technologies (eg, Taqman) to analyze the cultures and/or com-
pared them to a truly pluripotent stem cell line, as we have done. Our
results suggest that, although present, the levels of the pluripotent
stem cell markers OCT4 and NANOG, together with the lack of SOX2
expression, were not sufficient to suggest a pluripotent state of
hDPCs in any of our conditions. Regarding the NCSC phenotype, we
observed the expression of a large panel of relevant neural crest-
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related markers including SLUG, SNAIL1, SOX9, and NESTIN in our three
initial, isolating culture conditions by immunocytochemistry as well as
NESTIN by RT-qPCR. Thus, we provide evidence of neural crest-like phe-
notypes already in our monolayer cultures. However, the percentages of
P75 and STRO-1 positive cells varied with passage number. The P75
marker has been proposed as a neural crest marker for hDPC,27 while
STRO-1 has been widely studied as a mesenchymal stromal cell marker in
hDPCs.28 Therefore, the decrease in cells positive for P75 coupled with
the increase of STRO-1 suggests that the monolayer culture conditions
were supportive of a MSC phenotype rather than of a NCSC phenotype.
The latter is further supported by the low relative expression levels of
P75 and that only two hDPC-FBS cultures were expressing SOX10 by
RT-qPCR in monolayer conditions. The variable behavior observed in all
our cultures illustrates the heterogeneous nature of hDPCs when grown
as a monolayer, regardless of the serum or growth factors used to supple-
ment the initial cultures. Our findings somehow differ from the study by
Al-Zer et al12 that established hDPC cultures in a serum-free neurogenic
medium and found P75 and SOX10 expression by immunocytochemistry.
The discrepancies could be attributed to the different protocol for culture
establishment (explant outgrowth) and/or the coating matrix on the plate
(ie, the use of neuregulin-β1 and fibronectin).
Our findings led us to hypothesize that heterogeneity in our
hDPC cultures could lead to inefficacy in differentiation and that an
intermediate population may be required for neural maturation, as
shown by observations from the literature on hDPC-neural differenti-
ation.14,29-31 Together with increasing reports obtaining NCSCs from
other dental-derived stem cells,7,8,32,33 it is suggested that a neural
crest or neurogenic population needs to be induced or enriched. In
this regard, sphere aggregation has been used to enrich for a neural
crest-like phenotype in other tissues.15,32,34 Recent reports have also
supported the advantages of growing hDPC as sphere aggregates,
including multilineage differentiation and neural crest-derived pheno-
type. Nevertheless, those reports derive from cultures originally
established in serum-rich conditions, which could contain neural inhib-
itory factors.35,36 Thus, we aimed to grow and characterize hDPC
grown as neurospheres as a method to obtain a neural crest-derived
stem cell phenotype from all our conditions tested. Our sphere aggre-
gates showed a significant upregulation of SNAIL1 and P75 mRNA
levels, the latter particularly in OSCFM and BMP4 groups. An
enhanced NCSC phenotype on BMP4-derived spheres can be further
supported by the expression of SOX2, P75, and SOX10, in contrast to
the monolayer cells in which appeared undetected in later passaged
cultures by immunocytochemistry and RT-qPCR. Similarly, cultures
from adult palatum, periodontal ligament, dental pulp, or hair follicles
grown in defined conditions have been shown to express the neural
crest markers Sox10, Sox9, Snail1, Slug, P75, and Ap2a.14,34,37,38 Our
data represent a broader NCSC characterization from adult human
dental pulp compared to other authors,12-14 and validation that
NCSCs can be captured, using 3D cultures, from hDPCs. A variable
expression of NCSC markers was noted, however, even within the
same conditions. This could be a result of the heterogeneity of the
cultures and importantly, of patient-to-patient variation, as can be
implied from previous reports.6,39,40 Such variations must be consid-
ered for future clinical applications.
The addition of BMP4 to the initial growing conditions generally
increased the expression of important NCSC markers such as P75 and
SOX10 in hDPC-BMP4 neurospheres, as observed by immunocyto-
chemistry and RT-qPCR. Additionally, in vitro differentiation into
neural-like cells was qualitatively better from BMP4-containing cul-
tures, with cells developing neurites and expressing markers of matur-
ing neurons such as NFH, TUJ1, peripherin (PER), TAU, GAP43, and
SYN1. However, neuralization into more mature phenotypes would
need to be improved further. Cultures from all conditions had
undifferentiated, non-neural cells and in general, cells failed to migrate
out of the spheres. We cannot rule out the possibility of obtaining a
mature neural phenotype from all our hDPC culture conditions if left
for a longer period, as has been described by Gervois et al.15 Other
authors have encountered similar problems, when only a small frac-
tion of cells were able to trigger action potentials using the same pro-
tocol.41 It is possible that the heterogeneity present in hDPCs-NCSCs
limits a full neurogenic potential.35
However, the observed hDPC-BMP4 NCSC phenotype, as well as
the improved changes observed during their neural differentiation
in vitro, support the important role of BMP4 in sensory neuron and
cranio-facial neural crest induction.17,30,42,43 To provide further evi-
dence of the importance of BMP4 for the NCSC phenotype and neu-
ral differentiation, we also tested the effect of supplementing hDPC-
NCSCs (spheres) with BMP4 and, independently, transferring standard
hDPC-FBS cells to BMP4 culture medium conditions before neural
differentiation. As a result, we observed (a) the enhanced neural crest
phenotype observed in neurosphere formation supplemented with
BMP4, (b) the better neuralization observed in the FBS-BMP4-NEU
experiments, and (c) the apparent faster and pronounced changes
observed during neural differentiation of the basal hDPC-BMP4
in vitro, support its important role for the neural crest phenotype. Our
results suggest an important role of BMP4 in the neural crest-like phe-
notype of hDPCs.
Notably, the characterization of dental-related human NCSCs,
including those derived from gingival tissue, periodontal tissue, exfoli-
ated deciduous teeth, and adult human dental pulp, has gained
increasing interest for their potential use in neurodegenerative disor-
ders. Nevertheless, most reports are limited to describing the molecu-
lar resemblance to neural crest cells, while their actual differentiation
capacity is usually left untested, masking their actual translational
potential for regenerative medicine.7-9,32,33,37,44
Additionally, it would be important to evaluate a combination of
strategies to facilitate the application of oral-derived NCSCs in regen-
erative medicine, such as their incorporation in advanced man-
ufactured scaffolds or conduits for nerve repair and tissue engineering
(eg, bone regeneration).9,45,46
Finally, the field of dental pulp stem cells and their applications
would benefit from addressing specific diseases or targeted applica-
tions from preclinically relevant established cultures if we aim to
advance the use of dental pulp cells in regenerative medicine.
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5 | CONCLUSION
We have provided a detailed description of the culture of hDPC
from a wide variety of teeth, as well as a robust characterization
of the culture conditions. We have also shown that cells can
be directly established in serum-free medium in contrast to the
widely used serum-rich standard conditions. This should prove
highly advantageous in a preclinical setting. Also, hDPCs present
a basal neural crest-like phenotype that can be enhanced when
induced to form neurospheres (hDPC-NCSC). Furthermore,
BMP4 has a significant role in enhancing the neural crest-like
phenotype in human dental pulp. It is worth noting, however, that
there is a substantial level of heterogeneity and patient-to-
patient variation that should be considered for future clinical
applications.
Altogether, the present work details the culture and characteri-
zation of NCSCs from a broad cohort of human dental pulp samples
established in preclinically relevant serum-free conditions. Our
results should facilitate the culturing of these cells under good
manufacturing practice-compliant processes and encourage their use
in disease-specific models to advance their application in regenera-
tive medicine.
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